ES2432066T3 - Síntesis de 3-{[(2R)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1H-indol - Google Patents
Síntesis de 3-{[(2R)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1H-indol Download PDFInfo
- Publication number
- ES2432066T3 ES2432066T3 ES09751896T ES09751896T ES2432066T3 ES 2432066 T3 ES2432066 T3 ES 2432066T3 ES 09751896 T ES09751896 T ES 09751896T ES 09751896 T ES09751896 T ES 09751896T ES 2432066 T3 ES2432066 T3 ES 2432066T3
- Authority
- ES
- Spain
- Prior art keywords
- salt
- eletriptan
- formula
- acid
- oxalic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20090678 | 2009-04-22 | ||
| ITMI2009A000678A IT1393700B1 (it) | 2009-04-22 | 2009-04-22 | Sintesi di 3-{[(2r)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1h-indolo |
| PCT/EP2009/064850 WO2010121673A1 (en) | 2009-04-22 | 2009-11-09 | Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2432066T3 true ES2432066T3 (es) | 2013-11-29 |
Family
ID=41314669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09751896T Active ES2432066T3 (es) | 2009-04-22 | 2009-11-09 | Síntesis de 3-{[(2R)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1H-indol |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8426612B2 (https=) |
| EP (1) | EP2421853B1 (https=) |
| JP (1) | JP5663559B2 (https=) |
| CN (1) | CN102414198B (https=) |
| CA (1) | CA2756234C (https=) |
| ES (1) | ES2432066T3 (https=) |
| IT (1) | IT1393700B1 (https=) |
| WO (1) | WO2010121673A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102786514B (zh) * | 2012-07-26 | 2014-01-29 | 武汉人福医药集团股份有限公司 | 依来曲普坦的制备方法 |
| CN104341397A (zh) * | 2013-07-31 | 2015-02-11 | 上海威智医药科技有限公司 | 具晶型的依来曲普坦自由碱及其制法和应用 |
| CN105175397B (zh) * | 2015-09-15 | 2017-10-10 | 上海现代哈森(商丘)药业有限公司 | 一种氢溴酸依立曲坦合成方法 |
| JP2019502761A (ja) * | 2016-01-21 | 2019-01-31 | ラボラトリオス レヴィ エセエレ | ((r)−3−[(−1−メチルピロリジン−2−イル)メチル]−5−(2−フェニルスルホニルエチル)−1h−インドールを作製する方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL170330B1 (pl) | 1990-10-15 | 1996-11-29 | Pfizer | Sposób wytwarzania nowych pochodnych indolu PL PL PL PL PL PL |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9923314D0 (en) * | 1999-10-01 | 1999-12-08 | Pfizer Ltd | Acylation process |
| US20030166704A1 (en) | 2000-12-20 | 2003-09-04 | Pfizer Inc. | New process |
| GB0031094D0 (en) * | 2000-12-20 | 2001-01-31 | Pfizer Ltd | New Process |
| JP2006522790A (ja) | 2003-04-11 | 2006-10-05 | ファイザー・インク | エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物 |
| GB0317229D0 (en) * | 2003-07-23 | 2003-08-27 | Pfizer Ltd | Improved process |
| US6927296B2 (en) * | 2003-07-23 | 2005-08-09 | Pfizer Inc. | Process |
| EP2093224A1 (en) | 2007-05-01 | 2009-08-26 | Plus Chemicals B.V. | Process for preparing eletriptan hydrobromide form beta |
| US20080319205A1 (en) * | 2007-05-29 | 2008-12-25 | Roman Bednar | Process for preparing 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole |
| WO2009077858A2 (en) | 2007-12-17 | 2009-06-25 | Actavis Group Ptc Ehf | Novel hemioxalate salt of eletriptan |
| US20090299077A1 (en) | 2008-05-22 | 2009-12-03 | Vinod Kumar Kansal | Salts of (R)-5-(2phenylsulphonylethenyl)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole, 5-bromo-3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole and of eletriptan |
-
2009
- 2009-04-22 IT ITMI2009A000678A patent/IT1393700B1/it active
- 2009-11-09 ES ES09751896T patent/ES2432066T3/es active Active
- 2009-11-09 CA CA2756234A patent/CA2756234C/en active Active
- 2009-11-09 EP EP09751896.3A patent/EP2421853B1/en active Active
- 2009-11-09 CN CN200980158923.7A patent/CN102414198B/zh active Active
- 2009-11-09 JP JP2012506351A patent/JP5663559B2/ja active Active
- 2009-11-09 WO PCT/EP2009/064850 patent/WO2010121673A1/en not_active Ceased
- 2009-11-09 US US12/995,390 patent/US8426612B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2012524736A (ja) | 2012-10-18 |
| IT1393700B1 (it) | 2012-05-08 |
| CA2756234A1 (en) | 2010-10-28 |
| EP2421853A1 (en) | 2012-02-29 |
| JP5663559B2 (ja) | 2015-02-04 |
| US20110166364A1 (en) | 2011-07-07 |
| EP2421853B1 (en) | 2013-07-24 |
| CA2756234C (en) | 2017-01-03 |
| CN102414198A (zh) | 2012-04-11 |
| WO2010121673A1 (en) | 2010-10-28 |
| ITMI20090678A1 (it) | 2010-10-23 |
| CN102414198B (zh) | 2014-11-12 |
| US8426612B2 (en) | 2013-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI715658B (zh) | 二氫嘧啶並環化合物的晶型、製備方法和中間體 | |
| US11897843B2 (en) | Process for the preparation of enantiomerically enriched 3-aminopiperidine | |
| US20150038727A1 (en) | Method for preparing silodosin | |
| ES2432066T3 (es) | Síntesis de 3-{[(2R)-1-metilpirrolidin-2-il]metil}-5-[2-(fenilsulfonil)etil]-1H-indol | |
| CN102399166B (zh) | 光学异构的千金藤啶碱及其衍生物的制备方法 | |
| US9771317B2 (en) | Process for preparing lacosamide and related compounds | |
| TW519537B (en) | Process for the preparation of tricylic amino-alcohol derivatives | |
| CN105693603A (zh) | 改良的马来酸茚达特罗制备工艺 | |
| CN104837817B (zh) | 制备3‑氨基‑哌啶化合物的合成路线 | |
| ES2431359T3 (es) | Nuevo procedimiento para la preparación de Eletriptan | |
| ES2297415T3 (es) | Compuesto intermedio que se utiliza para la preparacion de pioglitazona. | |
| CN113906011B (zh) | 用于制备btk抑制剂的方法和中间体 | |
| JP2000007664A (ja) | 光学活性ピペラジン化合物、その中間体及びそれらの製造方法 | |
| CA3214107A1 (en) | New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds | |
| US4977274A (en) | 4-hydroxyindole derivatives, the process for preparation thereof and their use | |
| HK40060542A (en) | Processes and intermediates for preparing a btk inhibitor | |
| WO2005066124A1 (ja) | ピロリジン誘導体の製造法 | |
| JPH09241227A (ja) | 新規光学分割剤 | |
| JPH07247275A (ja) | オキサゾリジノン誘導体の単一のジアステレオマーの製造方法及びウレタン化合物の単一のジアステレオマーのフマル酸塩 | |
| WO2010090341A1 (ja) | 光学活性なトランス-4-アミノピペリジン-3-オール化合物の製造方法 | |
| HK1180677A1 (en) | Novel production method for isoquinoline derivatives and salts thereof | |
| HK1180677B (en) | Novel production method for isoquinoline derivatives and salts thereof |